Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Hammerstad

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neurology|May 29, 2001
DBS and diathermy interaction induces severe CNS damageJ G Nutt, V C Anderson, J H Peacock, et al.
Neurology|March 1, 1995
Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesisC S Lee, M Schulzer, E Mak, et al.
Neurosurgery|March 29, 2001
Assessments of axial motor control during deep brain stimulation in parkinsonian patientsL T Robertson, F B Horak, V C Anderson, et al.
The New England Journal of Medicine|February 23, 1984
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transportJ G Nutt, W R Woodward, J P Hammerstad, et al.
Clinical Neuropharmacology|October 1, 1994
Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patientsJ P Hammerstad, W R Woodward, J G Nutt, et al.
Annals of Neurology|October 1, 1993
The transport of L-6-fluorodopa and its metabolites from blood to cerebrospinal fluid and brainJ P Hammerstad, B D Pate, K A Hewitt, et al.
Clinical Neuropharmacology|January 1, 1986
Buspirone in Parkinson's diseaseJ P Hammerstad, J Carter, J G Nutt, et al.
Neurology|November 28, 2001
Interactions between deep brain stimulation and levodopa in Parkinson's diseaseJ G Nutt, S L Rufener, J H Carter, et al.
Neurology|May 1, 1994
Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patientsJ G Nutt, W R Woodward, R M Beckner, et al.
Neurology|August 1, 1997
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study GroupC H Adler, K D Sethi, R A Hauser, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neurology|May 29, 2001
DBS and diathermy interaction induces severe CNS damageJ G Nutt, V C Anderson, J H Peacock, et al.
Neurology|March 1, 1995
Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesisC S Lee, M Schulzer, E Mak, et al.
Neurosurgery|March 29, 2001
Assessments of axial motor control during deep brain stimulation in parkinsonian patientsL T Robertson, F B Horak, V C Anderson, et al.
The New England Journal of Medicine|February 23, 1984
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transportJ G Nutt, W R Woodward, J P Hammerstad, et al.
Clinical Neuropharmacology|October 1, 1994
Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patientsJ P Hammerstad, W R Woodward, J G Nutt, et al.
Annals of Neurology|October 1, 1993
The transport of L-6-fluorodopa and its metabolites from blood to cerebrospinal fluid and brainJ P Hammerstad, B D Pate, K A Hewitt, et al.
Clinical Neuropharmacology|January 1, 1986
Buspirone in Parkinson's diseaseJ P Hammerstad, J Carter, J G Nutt, et al.
Neurology|November 28, 2001
Interactions between deep brain stimulation and levodopa in Parkinson's diseaseJ G Nutt, S L Rufener, J H Carter, et al.
Neurology|May 1, 1994
Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patientsJ G Nutt, W R Woodward, R M Beckner, et al.
Neurology|August 1, 1997
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study GroupC H Adler, K D Sethi, R A Hauser, et al.
Pageof 3